Call Options

24 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$145.54 - $178.83 $101,878 - $125,181
700 Added 18.42%
4,500 $780,000
Q1 2024

May 01, 2024

SELL
$165.67 - $199.94 $1.84 Million - $2.22 Million
-11,100 Reduced 74.5%
3,800 $642,000
Q4 2023

Feb 12, 2024

BUY
$151.44 - $200.09 $257,448 - $340,153
1,700 Added 12.88%
14,900 $2.94 Million
Q3 2023

Nov 13, 2023

BUY
$167.14 - $192.77 $100,283 - $115,662
600 Added 4.76%
13,200 $2.3 Million
Q2 2023

Aug 10, 2023

BUY
$160.94 - $186.23 $128,752 - $148,984
800 Added 6.78%
12,600 $2.17 Million
Q1 2023

May 09, 2023

SELL
$145.48 - $175.02 $2.33 Million - $2.8 Million
-16,000 Reduced 57.55%
11,800 $1.96 Million
Q4 2022

Feb 10, 2023

BUY
$131.14 - $157.47 $236,051 - $283,446
1,800 Added 6.92%
27,800 $4.08 Million
Q3 2022

Nov 10, 2022

BUY
$148.29 - $182.55 $44,487 - $54,765
300 Added 1.17%
26,000 $3.86 Million
Q2 2022

Aug 15, 2022

SELL
$155.97 - $200.09 $1.22 Million - $1.56 Million
-7,800 Reduced 23.28%
25,700 $4.42 Million
Q1 2022

May 13, 2022

SELL
$181.39 - $234.03 $6.19 Million - $7.98 Million
-34,100 Reduced 50.44%
33,500 $6.32 Million
Q4 2021

Feb 11, 2022

BUY
$193.69 - $247.03 $445,487 - $568,169
2,300 Added 3.52%
67,600 $16.5 Million
Q3 2021

Nov 15, 2021

BUY
$189.29 - $209.69 $3.75 Million - $4.15 Million
19,800 Added 43.52%
65,300 $12.7 Million
Q2 2021

Aug 16, 2021

BUY
$155.9 - $187.99 $2.6 Million - $3.14 Million
16,700 Added 57.99%
45,500 $8.48 Million
Q1 2021

May 17, 2021

SELL
$144.0 - $169.39 $792,000 - $931,644
-5,500 Reduced 16.03%
28,800 $4.54 Million
Q4 2020

Feb 16, 2021

SELL
$157.07 - $174.35 $314,140 - $348,700
-2,000 Reduced 5.51%
34,300 $5.68 Million
Q3 2020

Nov 16, 2020

BUY
$137.1 - $165.37 $1.86 Million - $2.25 Million
13,600 Added 59.91%
36,300 $6 Million
Q2 2020

Aug 14, 2020

SELL
$111.92 - $142.53 $1.35 Million - $1.72 Million
-12,100 Reduced 34.77%
22,700 $3.11 Million
Q1 2020

May 15, 2020

SELL
$92.66 - $144.94 $1.56 Million - $2.43 Million
-16,800 Reduced 32.56%
34,800 $4.1 Million
Q4 2019

Feb 14, 2020

BUY
$116.25 - $133.25 $1.56 Million - $1.79 Million
13,400 Added 35.08%
51,600 $6.83 Million
Q3 2019

Nov 14, 2019

BUY
$112.57 - $128.43 $1.5 Million - $1.71 Million
13,300 Added 53.41%
38,200 $4.76 Million
Q2 2019

Aug 14, 2019

BUY
$97.98 - $114.28 $352,728 - $411,408
3,600 Added 16.9%
24,900 $2.83 Million
Q1 2019

May 15, 2019

BUY
$81.56 - $100.67 $1.12 Million - $1.38 Million
13,700 Added 180.26%
21,300 $2.14 Million
Q4 2018

Feb 14, 2019

BUY
$79.28 - $95.27 $467,752 - $562,093
5,900 Added 347.06%
7,600 $650,000
Q3 2018

Nov 14, 2018

BUY
$83.5 - $93.23 $141,950 - $158,491
1,700 New
1,700 $156,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $88.9B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Capstone Investment Advisors, LLC Portfolio

Follow Capstone Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.